Skip to content

Clinical trials

Endocrine System Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20133
20142
20161
20172
20191
20203
20215
20223
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status11
Recruiting3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
Eli Lilly and Company2
Shandong Provincial Hospital2
Visen Pharmaceuticals (Shanghai) Co., Ltd.2
AstraZeneca1
Chaohu Hospital of Anhui Medical University1
Daewoong Pharmaceutical Co. LTD.1
Guangzhou Women and Children's Medical Center1
Hepatopancreatobiliary Surgery Institute of Gansu Province1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases28
Metabolic Diseases9
Diabetes Mellitus8
Glucose Metabolism Disorders8
Thyroid Diseases6
Diabetes Mellitus, Type 25
Immune System Diseases5
Neoplasms5
Neoplasms by Histologic Type5
Neoplasms by Site5

Trials

Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.